116 related articles for article (PubMed ID: 36516653)
1. Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and CXCL8.
Numasaki M; Ito K; Takagi K; Nagashima K; Notsuda H; Ogino H; Ando R; Tomioka Y; Suzuki T; Okada Y; Nishioka Y; Unno M
Cell Immunol; 2023 Jan; 383():104652. PubMed ID: 36516653
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.
Heinhuis B; Koenders MI; van de Loo FA; Netea MG; van den Berg WB; Joosten LA
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4962-7. PubMed ID: 21383200
[TBL] [Abstract][Full Text] [Related]
3. Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines.
Heinhuis B; Plantinga TS; Semango G; Küsters B; Netea MG; Dinarello CA; Smit JWA; Netea-Maier RT; Joosten LAB
Carcinogenesis; 2016 Feb; 37(2):197-205. PubMed ID: 26678222
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway.
Park JS; Choi SY; Lee JH; Lee M; Nam ES; Jeong AL; Lee S; Han S; Lee MS; Lim JS; Yoon DY; Kwon Y; Yang Y
Cell Oncol (Dordr); 2013 Dec; 36(6):493-503. PubMed ID: 24114327
[TBL] [Abstract][Full Text] [Related]
5. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.
Sloot YJE; Rabold K; Ulas T; De Graaf DM; Heinhuis B; Händler K; Schultze JL; Netea MG; Smit JWA; Joosten LAB; Netea-Maier RT
Cell Oncol (Dordr); 2019 Oct; 42(5):691-703. PubMed ID: 31201646
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production.
Kang JW; Park YS; Lee DH; Kim MS; Bak Y; Park SH; Ham SY; Yang Y; Hong JT; Yoon DY
FEBS Lett; 2013 Nov; 587(23):3776-81. PubMed ID: 24396867
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
Adachi Y; Aoki C; Yoshio-Hoshino N; Takayama K; Curiel DT; Nishimoto N
Int J Cancer; 2006 Sep; 119(6):1303-11. PubMed ID: 16642474
[TBL] [Abstract][Full Text] [Related]
8. IL-32 promotes angiogenesis.
Nold-Petry CA; Rudloff I; Baumer Y; Ruvo M; Marasco D; Botti P; Farkas L; Cho SX; Zepp JA; Azam T; Dinkel H; Palmer BE; Boisvert WA; Cool CD; Taraseviciene-Stewart L; Heinhuis B; Joosten LA; Dinarello CA; Voelkel NF; Nold MF
J Immunol; 2014 Jan; 192(2):589-602. PubMed ID: 24337385
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of interleukin-32 isoforms alpha, beta, gamma, and delta in the gingival crevicular fluid and plasma of the patients with periodontitis.
Öngöz Dede F; Gökmenoğlu C; Deveci ET; Çelen S; Avci B; Kara C; Çanakçi V
J Periodontal Res; 2021 Jan; 56(1):83-92. PubMed ID: 32890410
[TBL] [Abstract][Full Text] [Related]
10. A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10.
Kang JW; Choi SC; Cho MC; Kim HJ; Kim JH; Lim JS; Kim SH; Han JY; Yoon DY
Immunology; 2009 Sep; 128(1 Suppl):e532-40. PubMed ID: 19740314
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma.
Harada A; Uchino J; Harada T; Nakagaki N; Hisasue J; Fujita M; Takayama K
Cancer Sci; 2017 Jan; 108(1):116-123. PubMed ID: 27783867
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of vascular endothelial growth factor and its receptor flt-1 in malignant pleural mesothelioma.
König J; Tolnay E; Wiethege T; Müller K
Respiration; 2000; 67(1):36-40. PubMed ID: 10705260
[TBL] [Abstract][Full Text] [Related]
13. IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.
Oh JH; Cho MC; Kim JH; Lee SY; Kim HJ; Park ES; Ban JO; Kang JW; Lee DH; Shim JH; Han SB; Moon DC; Park YH; Yu DY; Kim JM; Kim SH; Yoon DY; Hong JT
Oncogene; 2011 Jul; 30(30):3345-59. PubMed ID: 21423208
[TBL] [Abstract][Full Text] [Related]
14. VEGF-A, HGF and bFGF are Involved in IL-17A-mediated Migration and Capillary-like Vessel Formation of Vascular Endothelial Cells.
Numasaki M; Ito K
Iran J Immunol; 2021 Jun; 18(2):103-110. PubMed ID: 34190691
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.
Heinhuis B; Koenders MI; van den Berg WB; Netea MG; Dinarello CA; Joosten LA
J Biol Chem; 2012 Feb; 287(8):5733-43. PubMed ID: 22203669
[TBL] [Abstract][Full Text] [Related]
16. Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.
Eguchi R; Nakano T; Wakabayashi I
Oncogene; 2017 Feb; 36(5):714-722. PubMed ID: 27345409
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model.
Kobayashi H; Huang J; Ye F; Shyr Y; Blackwell TS; Lin PC
PLoS One; 2010 Mar; 5(3):e9458. PubMed ID: 20221440
[TBL] [Abstract][Full Text] [Related]
18. Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti-PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma.
Danlos FX; Texier M; Job B; Mouraud S; Cassard L; Baldini C; Varga A; Yurchenko AA; Rabeau A; Champiat S; Letourneur D; Bredel D; Susini S; Blum Y; Parpaleix A; Parlavecchio C; Tselikas L; Fahrner JE; Goubet AG; Rouanne M; Rafie S; Abbassi A; Kasraoui I; Breckler M; Farhane S; Ammari S; Laghouati S; Gazzah A; Lacroix L; Besse B; Droin N; Deloger M; Cotteret S; Adam J; Zitvogel L; Nikolaev SI; Chaput N; Massard C; Soria JC; Gomez-Roca C; Zalcman G; Planchard D; Marabelle A
Cancer Discov; 2023 Apr; 13(4):858-879. PubMed ID: 36669143
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.
Heinhuis B; Koenders MI; van Riel PL; van de Loo FA; Dinarello CA; Netea MG; van den Berg WB; Joosten LA
Ann Rheum Dis; 2011 Apr; 70(4):660-7. PubMed ID: 21187297
[TBL] [Abstract][Full Text] [Related]
20. Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma.
Davidson B; Vintman L; Zcharia E; Bedrossian C; Berner A; Nielsen S; Ilan N; Vlodavsky I; Reich R
Clin Exp Metastasis; 2004; 21(5):469-76. PubMed ID: 15672872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
